Narrow by location

DOT Changes Drug Testing List

Safety

The U.S. Department of Transportation (DOT) recently issued a final rule that expands the DOT’s current drug testing panel to include some semi-synthetic opioids:

  • Hydrocodon – Trade names Norco, Vicodin, Lortab, Vicoprofen and Riboxen
  • Hydromorphone – Trade name Dilasudid
  • Oxymorphone – Trade name Numorphan
  • Oxycodone – Trade name Eucodal

DOT-regulated employers will be required to test for these highly abused opioids beginning on Jan. 1, 2018.

This change was made to enhance safety, prevent opioid abuse and combat the growing opioid epidemic in the United States. Currently, the DOT requires drug testing of safety-sensitive employees in the transportation industries.

“The opioid crisis is a threat to public safety when it involves safety-sensitive employees involved in the operation of any kind of vehicle or transport,” said Secretary Elaine L. Chao. “The ability to test for a broader range of opioids will advance transportation safety significantly and provide another deterrence to opioid abuse, which will better protect the public and ultimately save lives.”

 

Safety Starts at the Point of Hire

By Mark Tinney, Construction Executive Job-specific behavioral assessment is proving to be an effective tool to improve workplace... »

Increase Employee Wellness in Construction

By Kevan Orvitz, Construction Executive Construction is an extremely demanding job, physically and mentally. Workers are required to... »

Improve Safety With Electronic Data Capture and Analysis

By Greg Norris, Construction Executive Paperwork tends to be despised on heavy construction sites, where crews and foremen... »

Think Safety First Near Railway Crossings

By: Brandon Kennedy, Traffic Designer, Sain Associates from Sain Associates blog Railway safety is a topic that cannot be... »

LEAVE YOUR COMMENT

Your email address will not be published. Required fields are marked *